3Yano A, Oda S, Fukami T, et al. Development of a cell-based assay system considering drug metabolism and immune- and in- flammatory-related {actors for the risk assessment of drug-in- duced liver injury[J]. ToxicolLett, 2014, 228(1) :13-24. 被引量：1
4Wang H, Xi S, Liu Z, et al. Arsenic methylation metabolism and liver injury of acute promyelocytie leukemia patients under- going arsenic trioxide treatment[J]. Environ Toxieol, 2013, 28 (5) :267-275. 被引量：1
5Theodoraki K, Arkadopoulos N, Nastos C, et al. Small liver remnants are more vulnerable to ischemia/reper{usion injury af- ter extended hepatectomies: a case-control study [J].World J Surg, 2012, 36(12):2895-2900. 被引量：1
6Harrill AH, Eaddy JS, Rose K, et al. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathologieal correlate in beagle dogs treated with GABAA receptor antagonist NP260[J]. Toxico- lApplPharmacol, 2014, 277(2):131-137. 被引量：1
7Huang X, Qin J, Lu S. Magnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced iniury[J]. Int J ClinExpPathol, 2014, 7(8): 4755-4764. 被引量：1
8EI-Bassyouni HT, Afifi HH, Eid MM, et al. Oxidative Stress -a Phenotypic Hallmark of Fanconi Anemia and Down Syn- drome: The Effect of Antioxidants[J]. Ann Med Health Sci Res, 2015, 5(3):205-212. 被引量：1
9Emadi A, Sadowska M, Carter-Cooper B, et al. Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemia[J], Leuk Res, 2015, 39(7):719-729. 被引量：1
10Eigendorff E, Hochhaus A. Acute leukemia in adults [J]. Path ologe, 2015, 36(5): 503-519. 被引量：1
